Correlation Between Spyre Therapeutics and Asure Software

Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and Asure Software at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and Asure Software into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Spyre Therapeutics and Asure Software, you can compare the effects of market volatilities on Spyre Therapeutics and Asure Software and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of Asure Software. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and Asure Software.

Diversification Opportunities for Spyre Therapeutics and Asure Software

0.06

Correlation Coefficient

Spyre Therapeutics  Asure Software

Significant diversification

The 3 months correlation between Spyre and Asure is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and Asure Software in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Asure Software and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with Asure Software. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Asure Software has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and Asure Software go up and down completely randomly.

Pair Corralation between Spyre Therapeutics and Asure Software

Given the investment horizon of 90 days Spyre Therapeutics is expected to under-perform the Asure Software. In addition to that, Spyre Therapeutics is 2.21 times more volatile than Asure Software. It trades about -0.18 of its total potential returns per unit of risk. Asure Software is currently generating about -0.18 per unit of volatility. If you would invest  977.00  in Asure Software on September 24, 2024 and sell it today you would lose (67.00) from holding Asure Software or give up 6.86% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Spyre Therapeutics  vs.  Asure Software

Spyre Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Spyre Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Asure Software

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Asure Software are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable basic indicators, Asure Software is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Spyre Therapeutics and Asure Software

The main advantage of trading using opposite Spyre Therapeutics and Asure Software positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, Asure Software can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Asure Software will offset losses from the drop in Asure Software's long position.

The idea behind Spyre Therapeutics and Asure Software pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.